Evidence map›Paper›PMID 38021116›Full record

ArticleBiomedical optics express2023

NY-ESO-1 antigen-antibody interaction process based on an TFBG plasmonic sensor.

Hang Qu, Linyao Tan, Fang-Cai Wu, Weiyuan Huang, Kaiwei Li, Xiaoyong Chen, Yi-Wei Xu, Xuehao Hu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical optics express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Hang QuResearch Center for Advanced Optics and Photoelectronics, Department of Physics, College of Science, Shantou University, Shantou, Guangdong 515063, China.
Linyao TanResearch Center for Advanced Optics and Photoelectronics, Department of Physics, College of Science, Shantou University, Shantou, Guangdong 515063, China.
Fang-Cai WuDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
Weiyuan HuangResearch Center for Advanced Optics and Photoelectronics, Department of Physics, College of Science, Shantou University, Shantou, Guangdong 515063, China.
Kaiwei LiKey Laboratory of Bionic Engineering of Ministry of Education, Jilin University, Changchun, China.
Xiaoyong ChenSchool of Electrical Engineering and Intelligentization, Dongguan University of Technology, Dongguan 523808, China.
Yi-Wei XuDepartment of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
Xuehao HuDepartment of Electromagnetism and Telecommunication, University of Mons, Boulevard Dolez 31, 7000 Mons, Belgium.ORCID https://orcid.org/0000-0003-0239-6144
Shantou University · CNDongguan University of Technology · CNJilin University · CNUniversity of Mons · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoantibodies against New York esophageal squamous cell cancer 1 (NY-ESO-1) play a crucial role in the diagnosis of esophageal cancer. In this work, a surface plasmonic tilted fiber Bragg grating (TFBG) biosensor is proposed for the detection of NY-ESO-1 antibody, as well as the investigation of the hook effect (which refers to the false negative result in some immunoassays when the concentration of antibodies in the sample is very high) during biomolecular binding between NY-ESO-1 antigen and antibody. The biosensor is made by an 18° TFBG coated with a 50-nm-thick gold film over the fiber surface together with NY-ESO-1 antigens attached to the metallic surface serving as bio-receptors. This biosensor can provide a limit of detection at a concentration of 2 × 10

Identifiers

PMID38021116
PMCPMC10659779
OpenAlexW4387570794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.